Bioethics, Biosafety & Entrepreuenship

8/6/2019 Bioethics, Biosafety & Entrepreuenship

1/65

INDUSTRIAL LICENSING VENTURE CAPITAL

BIOTECH PARK

BIOTECH INDUSTRIES IN INDIA & THE POTENTIAL

JOB OPPORTUNITIES.

Submitted by:

Shwetha

MSc Bt 4

th

Sem1


2/65

` Regulated under the Industries (Development &

Regulation) Act, 1951

` Granted by the Government of India in the

Secretariat for Industrial Assistance (SIA) on therecommendation of the Licensing Committee.

2


3/65

I. Industries retained under compulsory licensing,

ii. Manufacture of items reserved for small scale

sector by non-SSI units; and

iii. When the proposed location attracts locationalrestriction

iv. Industries reserved for the Public Sector

3


4/65

` Distillation and brewing of alcoholic drinks` Cigars and cigarettes of tobacco and manufactured tobacco

substitutes` Electronic Aerospace and defense equipment: all types` Industrial explosives including detonating fuses, safety fuses gun

powder, nitrocellulose and matches` Hazardous chemicals

(a) Hydrocyanic acid and its derivatives(b) Phosgene and its derivatives(c) Isocyanates and di-isocyanates of hydrocarbon, notelsewhere specified (example: Methyl Isocyanate);

` Drugs and Pharmaceuticals (according to modified Drug Policyissued in September, 1994 and subsequently amended inFebruary, 1999)

4


5/65

` An industrial undertaking is defined asa small-scale unit if the capitalinvestment in plant and machinerydoes not exceed Rs 10 million.

` Small-scale units can get registeredwith the Directorate ofIndustries/District Industries Centre ofthe State Government. Such units canmanufacture any item, and are also

free from locational restrictions.

5


6/65

` The Government has reserved certain items for

exclusive manufacture in the small-scale sector.

` Non small-scale units can manufacture items

reserved for the small-scale sector only afterobtaining an industrial license. In such cases, the

non-small scale unit is required to undertake an

obligation to export 50 per cent of the production

of SSI reserved items.

6


7/65

` Industrial undertakings are free to select the locationof their projects.

` Industrial License is required if the proposed locationis within 25 KM of the Standard Urban Area limits of

23 cities.Locational restriction does not apply:

` If the unit were to be located in an area designated asan industrial area before the 25th July, 1991.

`

non polluting industry i.e; Electronics, Computersoftware and Printing and any other industry.

7


8/65

Application in the prescribed form.(Form FC-IL)

Accompany with a crosseddemand draft of Rs.2500/-

Submit to the PR&C section in SIA

Decisions are usually taken within4-6 weeks of filing the application.

8


9/65

IEMare only required to file an IndustrialEntrepreneur Memoranda (IEM) in Part A, in theprescribed format (Form IEM).

(Form IEM) can be filed with the PR&C section in

SIA either in person or by post.

Submit along with a crossed DD of Rs.1000/- forup to 10 items proposed to be manufactured

> 10 items, an additional fee of Rs. 250 for up to10 additional items needs to be paid.

On filing the IEM, an acknowledgementcontaining the SIA Registration Number, forfuture reference, is issued.

9


10/65

` In case IEM is sent by post, the acknowledgement is also sentby post & no further approval is required.

` An IEM would stand cancelled if the proposal requirescompulsory license.

` Upon commencement of commercial production, Industrial

undertakings need to file information in Part B of the IEM toPR&C Section in SIA. No fee is to be paid for filing Part B.` All industrial undertakings whether or not exempt from

compulsory industrial licensing, are statutorily required to submitmonthly production return every month.

` This should reach the Industrial Statistics Unit (ISU) of the

Department positively by the 10th of the following month.

10


11/65

` SSI by virtue of their natural growth may exceed theinvestment limit prescribed for them.

` In such cases these units need to obtain a Carry-on-Business (COB) License based on the best production inthe preceding three years.

` No export obligation is fixed on the capacity for which the

COB license is granted.

PROCEDURE:

The application for COB license should be submitted inrevised form EE, which can be downloaded from theweb site http://www.dipp.gov.in along with a crosseddemand draft of Rs.2500/-.However, on further expansion of its capacity beyond thecapacity included in COB license, the unit would need toobtain an industrial license.

11


12/65

` The fee prescribed for various applications,

licenses are to be paid through crossed demand

draft drawn in favour of the Pay & Accounts

Officer,Department of Industrial Policy &Promotion, Ministry of Commerce & Industry,

payable at New Delhi.

12


13/65

` Terms to ensure that the project is managed in anenvironmentally sound and sustainable way.

` Issued by the Ministry of Environment & Forests underThe Environment (Protection) Act, 1986.

`

If investment in the project is less than Rs. 1 billion,such Environmental clearance is not necessary,except in cases of pesticides, bulk drugs andpharmaceuticals, asbestos and asbestos products,integrated paint complexes, mining projects, tourismprojects of certain parameters, tarred roads in

Himalayan areas, distilleries, dyes, foundries andelectroplating industries.

13


14/65

` Capital that is invested in a project where there is

a substantial element of risk relating to the future

creation of profits and cash flows. Risk capital is

invested as shares rather than as a loan and theinvestor requires a higher rate of return" to

compensate him for his risk.

14


15/65

` Seed Money: Low level financing needed to prove a newidea (Often provided by "angel investors")

` Start-up: Early stage firms that need funding for expensesassociated with marketing and product development

` First-Round: Early sales and manufacturing funds` Second-Round: Working capital for early stage companies

that are selling product, but not yet turning a profit` Third-Round:Also called Mezzanine financing, this is

expansion money for a newly profitable company` Fourth-Round:Also called bridge financing, 4th round is

intended to finance the "going public" process

15


16/65

Early Stage Finance

Seed Capital

Start up Capital

Early/First StageCapital

Later/ThirdStage Capital

Later Stage Finance

Expansion/Development Stage

Capital

ReplacementFinance

ManagementBuy Out and

Buy ins

Turnarounds

Mezzanine/Bridg

e Finance16


17/65

17


18/65

` Venture capitalist prefer to invest in"entrepreneurial businesses". This does notnecessarily mean small or new businesses.

` As a rule of thumb, unless a business canoffer the prospect of significant turnover

growth within five years, it is unlikely to beof interest to a venture capital firm.` Venture capital investors are only interested in

companies with high growth prospects, whichare managed by experienced and ambitiousteams who are capable of turning their

business plan into reality.

18


19/65

` Venture capital firms usually look to retain theirinvestment for between three and seven years ormore.

` The term of the investment is often linked to thegrowth profile of the business. Investments inmore mature businesses, where the businessperformance can be improved quicker and easier,are often sold sooner than investments in early-

stage or technology companies where it takestime to develop the business model.

19


20/65

` First half of the 20th century :domain of wealthyindividuals and families

` Vanderbilts, Whitneys, Rockefellers, and Warburgswere notable investors in private companies in the first

half of the century` Before World War II money orders (originally known as

"development capital") were primarily the domain ofwealthy individuals and families.

` after World War II capital firms1946:AmericanResearch and Development Corporation. (ARDC)founded by Georges Doriot and J.H. Whitney &Company

20


21/65

` ARDC encouraged private sector investments inbusinesses run by soldiers who were returning fromWorld War II.

` capital sources : wealthy families` ARDC continued investing until 1971 with the

retirement ofDoriot. In 1972, Doriot merged ARDCwith Textron after having invested in over 150companies.

` JH Whitney & Co:` famous investment was in Florida Foods Corporation` The company developed an innovative method for

delivering nutrition to American soldiers, which latercame to be known as Minute Maid orange juice and

was sold to The Coca-Cola Company in 1960.

21


22/65

` Depending on your business type, the venture capital

firm you approach will differ.` When approaching a VC firm, consider their portfolio:1. Business Cycle: Do they invest in budding or

established businesses?2. Industry: What is their industry focus?

3. Investment: Is their typical investment sufficient foryour needs?

4. Location:Are they regional, national or international?5. Return: What is their expected return on

investment?

6. Involvement: What is their involvement level?

22


23/65

` Venture partners Venture partners are expected to

source potential investment opportunities ("bring in

deals") and typically are compensated only for those

deals with which they are involved.

` Principal This is a mid-level investment professional

position, and often considered a "partner-track"

position. Principals will have been promoted from a

senior associate position or who have commensurate

experience in another field such as investmentbanking ormanagement consulting.

23


24/65

` Associate This is typically the most junior apprenticeposition within a venture capital firm. After a few successfulyears, an associate may move up to the "senior associate"position and potentially principal and beyond. Associateswill often have worked for 12 years in another field such

as investment banking ormanagement consulting.` Entrepreneur-in-residence (EIR) EIRs are experts in a

particular domain and perform due diligence on potentialdeals. EIRs are engaged by venture capital firmstemporarily (six to 18 months) and are expected to developand pitch startup ideas to their host firm (although neither

party is bound to work with each other). Some EIR's moveon to executive positions within a portfolio company.

24


25/65

` Most venture capital funds have a fixed life of 10 years, with thepossibility of a few years of extensions to allow for private companiesstill seeking liquidity. The investing cycle for most funds is generallythree to five years, after which the focus is managing and makingfollow-on investments in an existing portfolio.

` This model was pioneered by successful funds in Silicon

Valley through the 1980s to invest in technological trends broadly butonly during their period of ascendance, and to cut exposure tomanagement and marketing risks of any individual firm or its product.

` In such a fund, the investors have a fixed commitment to the fund thatis initially unfunded and subsequently "called down" by the venturecapital fund over time as the fund makes its investments.

` There are substantial penalties for a Limited Partner (or investor) that

fails to participate in a capital call.

25


26/65

` It can take anywhere from a month or so to

several years for venture capitalists to raise

money from limited partners for their fund.

` At the time when all of the money has been

raised, the fund is said to be closed and the 10

year lifetime begins. Some funds have partial

closes when one half (or some other amount) of

the fund has been raised.

` "Vintage year" generally refers to the year in

which the fund was closed and may serve as a

means to stratify VC funds for comparison.

26


27/65

` Venture capitalists are compensated through a combination ofmanagement fees and carried interest (often referred to as a "two and20" arrangement):

` Management fees an annual payment made by the investors in thefund to the fund's manager to pay for the private equity firm'sinvestment operations.[25] In a typical venture capital fund, the general

partners receive an annual management fee equal to up to 2% of thecommitted capital.` Carried interest a share of the profits of the fund (typically 20%),

paid to the private equity funds management company as aperformance incentive. The remaining 80% of the profits are paid to thefund's investors[25] Strong Limited Partner interest in top-tier venturefirms has led to a general trend toward terms more favorable to the

venture partnership, and certain groups are able to command carriedinterest of 25-30% on their funds.

27


28/65

` Venture capital, as an industry, originated in the United States and Americanfirms have traditionally been the largest participants in venture deals and the

bulk of venture capital has been deployed in American companies.` Increasingly, non-US venture investment is growing and the number and size of

non-US venture capitalists have been expanding.

` Venture capital has been used as a tool foreconomic development in a varietyof developing regions.

` In many of these regions, with less developed financial sectors, venture capitalplays a role in facilitating access to finance forsmall and medium

enterprises (SMEs), which in most cases would not qualify for receiving bankloans.

` In the year of 2008, while the Venture Capital fundings are still majorlydominated by U.S. (USD 28.8 B invested in over 2550 deals in 2008), comparedto International fund investments (USD 13.4 B invested in everywhere else),there have been an average 5% growth in the Venture capital deals outside ofthe U.S- mainly in China, Europe and Israel[11].

` Geographical differences can be significant. For instance, in the U.K., 4% of

British investment goes to venture capital, compared to about 33% in the U.S

28


29/65

` A science park orscience and technology park is

an area with a collection of buildings dedicatedto scientific research on a business footing.

` There are many approximate synonyms for "sciencepark", including research park, technologypark, technopolis andbiomedical park.

` The appropriate term typically depends on the type ofscience and research in which the park's entitiesengage, but many of these developments are namedaccording to which term gives the park the bestprofitability and naming advantages. Often, scienceparks are associated with or operated by institutions ofhigher education (colleges and universities).

29


30/65

` These parks differ from typical high-technologybusiness districts in that science parks and the like aremore organized, planned, and managed.

` Typically businesses and organizations in the parksfocus on product advancement and innovation asopposed to industrial parks that focus onmanufacturing and business parks that focus onadministration.

`

Science and technology parks are encouraged bylocal government, in order to attract new companies totowns, and to expand theirtax baseand employment opportunities to citizens.

` Land and other taxes are usually waived off orreduced along a number of years, in order to attractnew companies for the science and technologicalparks.

30


31/65

The world's first science park started in the early

1950s and foreshadowed the community knowntoday as Silicon Valley.

` Purpose

` Sharing of ideas

` Launching new companies

31


32/65

`

Have access to qualified research and development personnel inthe areas of knowledge in which the park has its identity.` Be able to market its high valued products and services.` Have the capability to provide marketing expertise and

managerial skills to firms, particularly Small and Medium-sizedEnterprises, lacking such a resource.

`

Be inserted in a society that allows for the protection of productor process secrets, via patents, security or any other means.` Be able to select or reject which firms enter the park. The firm's

business plan is expected to be coherent with the science parkidentity.

` Have a clear identity, quite often expressed symbolically, as the

park's name choice, its logo or the management discourse.

32


33/65

` Have a management with established or recognisedexpertise in financial matters, and which has presentedlong term economic development plans.

` Have the backing of powerful, dynamic and stableeconomic actors, such as a funding agency, political

institution or local university.` Include in its management an active person of vision, with

power of decision and with high and visible profile, who isperceived by relevant actors in society as embodying theinterface between academia and industry, long-term plansand good management.

` Include a prominent percentage ofconsultancy firms, aswell as technical service firms, including laboratories andquality control firms.

33


34/65

` The Association of University Research Parks (AURP), anon-profit association made up of university-affiliated researchparks, defines university research and science parks as a

property-based venture, which has certain characteristics, ofwhich include:` Master planned property and buildings designed primarily for

private/public research and development facilities, hightechnology and science based companies, and support services.

` A contractual, formal or operational relationship with one or more

science/research institutions of higher education.` A role in promoting the university's research and developmentthrough industry partnerships, assisting in the growth of newventures and promoting economic development

` A role in aiding the transfer of technology and business skillsbetween university and industry teams A role in promotingtechnology-led economic development for the community orregion.

34


35/65

` The setting up of a separate Department of Biotechnology(DBT), under the Ministry of Science and Technology in1986 gave a new impetus to the development of the field ofmodern biology and biotechnology in India.

` In more than a decade of its existence, the department has

promoted and accelerated the pace of development ofbiotechnology in the country. Through several R&Dprojects, demonstrations and creation of infrastructuralfacilities a clear visible impact of this field has been seen.

` The department has made significant achievements in thegrowth and application of biotechnology in the broad areas

of agriculture, health care, animal sciences, environment,and industry.

35


36/65

` In India, more than a decade of concerted effort in research anddevelopment in identified areas of modern biology andbiotechnology have given rich dividends.

` Initiatives have been taken to promote transgenic research inplants with emphasis on pest and disease resistance, nutritionalquality, silk-worm genome analysis, molecular biology of humangenetic disorders, brain research, plant genome research,development, validation and commercialisation of diagnostic kitsand vaccines for communicable diseases, food biotechnology,biodiversity conservation and bioprospecting, setting up ofmicropropagation parks and biotechnology based developmentfor SC/ST, rural areas, women and for different States.

36


37/65

` The DBT has set up task forces and expert committeeswith the involvement of eminent and active scientists fromall over the country to advise on the identification of thrustareas in Biotechnology for financial support. As a resultbiotechnology has received a significant fill-up in the

country with adequate support from the Govt. of India.` Fifteen Task forces and various expert/steering committees

of the department met two or four times during the year toreview and monitor the on going projects and also considernew proposals in the priority areas. A special thrust hasbeen given during the year on formulation and funding of

new projects specially multi-institutional andinterdisciplinary as per the priority of the tenth plan.

37


38/65

` Agriculture Biotechnology

` Animal Biotechnology (Last Updated: 06.01.2010)

` Aquaculture and Marine Biotechnology (Last Updated: 06.01.2010)

` Basic Research Modern Biology (Last Updated: 12.11.2009)

` Biodiversity Conservation and Environment

` Bioengineering

` Biological Agents for Agriculture(Last Updated: 09.12.2010)

` Bioinformatics (Last Updated: 20.01.2010)

` Biotech Product and Process Development` Biotechnology Programmes for SC/ST & Rural population

` Biotechnology Programme for Women

` Food and Nutrition Security

` Human Genetics and Genome Analysis

` Human Resource Development

` Infectious Disease Biology

` Infrastructure & Centers of Excellence` Inter-disciplinary Research Committee (IDRC) in Biotechnology

` Medicinal and Aromatic Plants (Last Updated: 20.01.2010)

` Plant Biotechnology

` Seri Biotechnology (Last Updated: 21.01.2010)

` Stem Cell Biology

38


39/65

` Plant,Animal, Human and Microbial Genomics: The specific areasof collaboration include comparative genomics of pathogenic microbes,mapping of buffalo and silk worm genome, identification of genomicsfactors responsible for genetics disorders and functional genomicsinvolving high throughput facilities such as microarrays and proteomics.

` Basic Research in New Biology: Medium term collaboration in basic

research for understanding molecular and genetic phenomena ofpathogenesis in plants, animals and human, plant molecular biology,biosensor development, metabolic and tissue engineering are importantthrough joint research and establishment of centres of excellence.

` Product and Process Oriented Research: Collaboration in terms ofscale up / field trials and validations through technology transferinvolving both techniques and materials would also be taken up.

39


40/65

` Three DBT sponsored Training Programmes /Workshops were organized. The participants fromresearch institutes, industries, universities andentrepreneurs were trained.

` 243 graduate and postgraduate students (120Bioinformatics & 123 Biotechnology) received shortterm (one to six months) training.

` 500 beneficiaries (Managers, Officers of various

research institutes and industries, Students) wereexposed on biotechnology related enterprises andactivities.

40


41/65

` 150 farmers were trained in agri-biotechnology likebiofuel, tissue culture, biofertilizers, vermicompostingetc.

` 500 farmers visited the Park and were exposed toagri-biotechnology related activities and were briefedabout benefits they can have from the Park.

` Students from 10 educational institutions wereexposed to biotechnology, bioinformatics and agri-biotechnology activities and were briefed aboutbiotechnology related entrepreneurship and futurecareer prospects in biotechnology.

` CEO delivered 16 lectures in National / Internationalprogrammes.

41


42/65

` CEO participated in 12 National / International conferences /workshops.

` 16 publications were communicated / published / accepted forpublication in peer review journals.

` Biotech Park represented in Bio-2008 at San Diego, USA whereCEO delivered two lectures apart from participation in businesspromotion meetings.

` CEO / Scientists of Biotech Park participated in 12 academicmeetings.

` Scientists of Biotech Park organized programmes and

participated in research related meets on Nano Biotechnology,Traditional medicines, Bioinformatics, Biobusiness, IntellectualProperty & Networking to create awareness, networking amongstbiotechnology stakeholders and to sensitize people.

42


43/65

` International Employers look for cross-disciplinaryeducation, as Biology problems are too big to be solved bypeople trained in only one discipline.

` The aspirants need to possess science and technologybasics, training in computer use and information

technology, and education in biotechnology & bioethics toanticipate and present options for solving prickly socialissues.

` Community and four-year college training in biology andrelated disciplines, including integrated science andtechnology programs that incorporate computer science,

information technology chemistry, biology, engineeringprinciples, and bioethics, are preferred.

43


44/65

` Private sector pharmaceutical companies

generally offer Rs.12000- 20000 per month to an

entry-level postgraduate. Those employed as

researchers in government sector can have a

starting salary of Rs.9000 per month along with

government perks/allowances.

44


45/65

` Job opportunities for postgraduates in biotechnology areincreasing in India. Students can explore job options in thefollowing fields:

` Research & Development:Research and Development is the chief component of

biotechnology. So from the entry level to the higer position,every type of biotech job in this segment is available. Youcan become a Scientific Director, Scientist, ResearchAssociate, Research Assistant, BioinformaticsScientist/Engineer, Bioinformatics Analyst/Programmer,Molecular Modeler, Facility Manager/Supervisor (Animal

Sciences), Veterinarian, Lab Assistant or Glasswasher.

45


46/65

` Clinical Research:

Clinical research in the main thing behind any job in biotechnology. You can become

Clinical Research Manager, Biostatistician, Clinical Data Manager/Associate,

Manager of Regulatory Affairs or Medical Affairs Director.

` SAS:

Its a part ofclinical data management.

SCOPE

* Statistical Analysis of Clinical and Research Data using SAS SoftWare.

* Prepare Custom derived SAS Data Sets.

* Help ion Programming for New Drug Applications(NDAs).* Preparing repots for Drug Development (Phases I - IV).

you can become a clinical SAS programmer : to carry out various tasks covering all

the aspects that are involved in the Business administration i.e. from writing reports

to creating marketing strategies.

46


47/65

` Biotech Pharmaceutical Jobs:Here you can become a clinical pharmacist, clinical researcher,pharmaceutical representatives, process engineer, quality control manager.This career in biotech is very lucrative but you must have a desire todiscover new things that are beneficial for humans & environment.

` Biotech Sales Jobs:To do biotech sales job you must have bachelor's degree and experience /knowlegde in the same field. You must be familiar with all the pharmaproducts of the company in detail to have a biotech sales job. Companiesthat sell medical products must be targeted to have career in this sector.

47


48/65

` Company Profile: Pepo Technologies sets a new trend inthe Life science industry, It offers exclusive expertise in HRin the science field.

` Experience: 0 2 Years` Compensation: Rupees 1,25,000 2,50,000

Education: Science, msc,bsc, medical, pharm,biotechnologyRole: Pharmacist/Chemist/Bio ChemistJob Description: To analyze the document ofmicrobiology. To use tools for analyzing and interpretationof information.

` Email Address: [email protected]:44-91-9710905599

48


49/65

` BioCOS Life Sciences` G-05, Tech Park Mall,

International Technology Park Bangalore(ITPB)White Field Road,Bangalore - 560066

` Bio skills`

` Computational biology` molecular biology` drug design and Discovery` Microarrays data and image processing

` proteomics and` transcriptomics high throughput data analysis/Genetic

regulatory` networks/pathways/genomic signal processing

49


50/65

` [email protected]

` # 49/2, Gubbi Cross, Bengaluru, Karnataka

560077080 6530 9009` Category: Biotech Industry

`

BiOZEEN undertakes Bioprocess Equipment

Manufacturing, Consultancy Services, ManpowerTraining and Bioprocess Research.

50


51/65

` Genome Valley is India's first systematically

developed R&D cluster with the largest concentrationof biotech, biopharmaceutical & other life science

companies. Spread across 600 Sq. Kms of area,

Genome Valley has four prominent clusters

` A few prominent companies in the cluster includeAdvanta, Aptuit Laurus, AMRI, Bharat Biotech,

Biological E Ltd, Dupont, Diacel Chiral, Grace

Davison, Globion Bio, ITW Performance Fluids, J K

Seeds, Lonza, Monsanto,Maktheshim Agan, Nektar,Pioneer Seeds, RCC Laboratories, United States

Pharmacopoeia, Unique Biotech, Vimta Labs, &

Zenotech among others.

51


52/65

` three core businesses:` Pharmaceutical Services and Active Ingredients,

comprising our Active Pharmaceuticals and CustomPharmaceuticals businesses;

` Global Generics, which includes branded andunbranded generics; and

` Proprietary Products, which includes New ChemicalEntities (NCEs), Differentiated Formulations, andGeneric Biopharmaceuticals.

` http://www.drreddys.com/careers/current_openings.asp

` Hyderabad, Andhra Pradesh

52


53/65

` Zeus Biotech energizes and protects animal life by

harnessing the power of microbiology.

` Our mission is to make poultry / pig farming

profitable to the farmers by harnessing the powerof microbiotechnology in the field of animal health.

`

` A-114,industrial estate,hebbal, Mysore,

Karnataka0821 254 0144`

53


54/65

` Abexome is looking for bright and young professionals,with master's degree in any stream of biology, and having astrong understanding of molecular biology andimmunology, to join the team. Prior experience in making

immunology products will be an advantage.` Yeshwanthpur, Bengaluru, Karnataka` [email protected]` Abexome Biosciences Pvt Ltd

No 78/1, 2nd Main Road, Raghavendra Layout, Off TumkurRoad, Yeshwanthpur, Bangalore 560022, INDIA

54


55/65


56/65

` Aurigene Discovery Technologies Limited, India is a DrugDiscovery Biotech engaged in small molecule and peptide drugdiscovery.

` Aurigenes key businesses are Collaborative Drug Discoverypartnerships, Licensing and Drug Discovery services.

` Aurigene currently runs over 20 Discovery programs with 9collaborators world-wide, spanning Big Pharma as well assuccessful Biotechs.

` [email protected]` http://www.aurigene.com/?page_id=155 - more info ` 39-40, KIADB Industrial Area, Electronic City, 560100, Hosur Rd,

Bengaluru, Karnataka0` Category: Biotechnology

56


57/65

` Professional Biotech Pvt. Ltd., founded in 1996 istoday the leading diagnostic solution provider inLife Sciences in India. As the name itselfsuggests, we are a Professionally managed

Company with an exponential growth in the pastfew years

` For a challenging career with us in the field ofcutting-edge biotechnologies send you resume

and a cover letter toProfessional Biotech PvtLtd

` Email: [email protected]

57


58/65

` Polyclone Bioservices is a molecular biology and genomicscompany that synergistically combines in vitro and insilico approaches to address target and biomarkerdiscovery & validation challenges. We work with Bio-

Supply, Biotech Platform and Drug Discoverycompanies and help them cost effectively achieve theirresearch and product goals in quicker time.

` Polyclone is headquartered in Bangalore, India withoperations in Europe and the US.

` [email protected] in MS Word format with

description of experience and your qualification in reversechronological order

` 40th Cross, 5th Block, Jayanagar, Bengaluru, Karnataka560041080 2663 8766

58


59/65

` Richcore Lifesciences Pvt Ltd

Plot No. 204 and 237, Bommasandra - Jigani Link Road, KIADB

Industrial Area, Bengaluru

` Strand Life Science

5th Floor, Kirloskar Business Park,, Bellary Road, Hebbal, Bengaluru,

Karnataka 560024080 4078 7263

` Multiplex Biotech Private Limited180, 1st Main Road, Mahalakshmipuram, Bengaluru, Karnataka

560086080 2349 7464

` Krishnendra Nursery & Biotech

9-159, 1st Block, Jayanagar, Bengaluru, Karnataka 560011080 26567594

59


60/65

` Amala Biotech Systems Pvt Ltd

# 856, Iind Stage, 18th Main, 14th Cross, B S K, Bengaluru,Karnataka 560070080 2671 5756

` JH BIO Innovations Pvt Ltd

3 2nd floor shivalaya arcade sanjay 560 094, 3rd Main,Bengaluru, Karnataka 560085080 2341 8944

` Trigenesis Lifesciences

No 160, 5th Main road, Chamarajpet, Bengaluru, Karnataka560018080 4215 4535

`

Alltech Biotechnology Pvt LtdNo.3, 6th Cross, Old Airport Rd, 560038, Kodihalli,Bengaluru, Karnataka080 2525 1991

60


61/65

` Spinco Biotech Pvt. Ltd.,Mahalaxmipuram, 143, 11th B, Cross,, Bengaluru, Karnataka 560086093

42 506104

`

BioTecNika Info Labs Pvt Ltd#2628, 4th Floor 27th Main, Sector 1, HSR Layout, Bengaluru, Karnataka560034080 3249 4384

` Nexus Biotech#157,12th main,nagendra block,muneshwara block, land mark k r

hospital, banglore, Karnataka 560050

080 2642 2533

` NupurBiotech Pvt Ltd/Nupur Dreamz

83, 80 Feet Road, Bengaluru, Karnataka 560094080 2333 8096

` Scientific International - Scientific Instruments Source

#10, 2nd Cross, Veerabhadra Nagar,, Basavanagar, Bengaluru,Karnataka 56003709899890998

61


62/65

` Enzyme India Private Limited

Flat 9 (FF) Spencer House, 82 Coles Road, Bengaluru,Karnataka 560005093 42 190781

` Karnataka Biotechnology & International Technology

9, 2nd Floor, Uni Building, V A Nagar, Thimmaiah Road,Bengaluru, Karnataka 560052080 2220 7006

` Prithvi Biotech India Private Limited

No. 195, 7th Cross, 1st Stage, Indiranagar, Bengaluru,Karnataka 560038080 2525 0397

`

Helix Biotech Ltd20th Km, Hosur Road, Bengaluru, Karnataka 5612290802842 2169

62


63/65

` Institute of Bioinformatics &

AppliedBiotechnology(ABAB)

G-05, Tech Park Mall, International Technology Park

Bangalore, Whitefield Road, Bengaluru, Karnataka

560066080 2841 6034

` Bangalore Biotech Event

9, Thimmaiah Road, Bengaluru, Karnataka560052080 2220 1916

63


64/65

` Reference

` Wikipedia

` The big book of small business- Tom Gegax with PhilBolsta

` Biospectrum

` THANKSTO:

` Sreenivas Makula Executive-Quality AssuranceBiocon Biopharmaceuticals

` Sudharshan Management Staff At Cipla

` Kalpa Poonacha Human Resources at BioconSyngene International Limited

` Satheesh HEAD HR&IR at Cipla

64


65/65

Documents

Bioethics, Biosafety & Entrepreuenship